Evidence map›Paper›PMID 18782852›Full record

ArticleHuman molecular genetics2008

Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure.

Mahmoud Reza Mansouri, Jens Schuster, Jitendra Badhai, Eva-Lena Stattin, Ralf Lösel, Martin Wehling, Birgit Carlsson, Outi Hovatta, Per Olof Karlström, Irina Golovleva and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 134 citations in OpenAlex.

  1. The Genetics of Non-Syndromic Primary Ovarian Insufficiency: A Systematic Review.International journal of fertility & sterility · 2019
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Ovarian dysfunction in women with Turner syndrome.Frontiers in endocrinology · 2023
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Mahmoud Reza MansouriDepartment of Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Jens Schuster
Jitendra Badhai
Eva-Lena Stattin
Ralf Lösel
Martin Wehling
Birgit Carlsson
Outi Hovatta
Per Olof Karlström
Irina Golovleva
Daniela Toniolo
Silvia Bione
John Peluso
Niklas Dahl
Uppsala University · SEHeidelberg University · DENational Research Council · ITUmeå University · SEKarolinska Institutet · SEUConn Health · USUppsala University Hospital · SE

Funding

Progesterone regulation of human luteal cell viabilityR03HD050298 · NICHD · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI PELUSO, JOHN J · 2005 to 2006
$146k
NICHD NIH HHS HD050298NICHD NIH HHS HD0552740NICHD NIH HHS R03 HD050298Telethon GGP05029
6 · The paper itself

Abstract

Premature ovarian failure (POF) is characterized by hypergonadotropic hypogonadism and amenorrhea before the age of 40. The condition has a heterogeneous background but genetic factors are demonstrated by the occurrence of familial cases. We identified a mother and daughter with POF both of whom carry an X;autosome translocation [t(X;11)(q24;q13)]. RNA expression studies of genes flanking the X-chromosome breakpoint revealed that both patients have reduced expression levels of the gene Progesterone Receptor Membrane Component-1 (PGRMC1). Mutation screening of 67 females with idiopathic POF identified a third patient with a missense mutation (H165R) located in the cytochrome b5 domain of PGRMC1. PGRMC1 mediates the anti-apoptotic action of progesterone in ovarian cells and it acts as a positive regulator of several cytochrome P450 (CYP)-catalyzed reactions. The CYPs are critical for intracellular sterol metabolism, including biosynthesis of steroid hormones. We show that the H165R mutation associated with POF abolishes the binding of cytochrome P450 7A1 (CYP7A1) to PGRMC1. In addition, the missense mutation attenuates PGRMC1's ability to mediate the anti-apoptotic action of progesterone in ovarian cells. These findings suggest that mutant or reduced levels of PGMRC1 may cause POF through impaired activation of the microsomal cytochrome P450 and increased apoptosis of ovarian cells.

Indexed as

Gene ExpressionAdolescentAdultApoptosisChromosomes, Human, XCytochrome P-450 Enzyme SystemDNA MethylationFemaleHumansMembrane ProteinsMutation, MissensePrimary Ovarian InsufficiencyProtein Structure, TertiaryReceptors, ProgesteroneTranslocation, GeneticYoung AdultCytochrome P-450 Enzyme SystemMembrane ProteinsPGRMC1 protein, humanReceptors, Progesterone

Identifiers

PMID18782852
PMCPMC2722898
OpenAlexW2109192557

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.